Flash e-reader

 Go to e-reader chapter








Table 5.6c

Immunosuppression Use for Induction by Steroid Use at Discharge, 2005 to 2009

Recipients with Kidney Transplants

  No Steroids Used for Maintenance Steroids Used for Maintenance
N % N %
Functioning Graft with Immunosuppression Info at Discharge 25,846 100.0% 54,774 100.0%
Induction Drugs 422 1.6% 593 1.1%
Atgam/NRATG/NRATS
OKT3 32 0.1% 139 0.3%
Thymoglobulin 12,631 48.9% 22,359 40.8%
Zenapax 1,827 7.1% 7,047 12.9%
Simulect 2,325 9.0% 11,269 20.6%
Campath 6,549 25.3% 2,077 3.8%
Rituximab 227 0.9% 408 0.7%
No Induction Drug Reported 3,316 12.8% 13,149 24.0%


Source: OPTN/SRTR Data as of October 1, 2010.

Includes patients with a functioning graft at discharge.

Steroids used for induction are not counted.

Individual induction drug percentages will not necessarily add up to 100 percent, as patients may be prescribed more than one induction drug.